These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38734500)

  • 1. Enhancing oncogenic signaling to kill cancer cells.
    Noeparast M; Timofeev O; Pichler M
    Trends Pharmacol Sci; 2024 Jun; 45(6):475-477. PubMed ID: 38734500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
    Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
    ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and Emerging Targeted Therapies of Colorectal Cancer.
    Finnberg N; Gokare P; El-Deiry WS
    Curr Clin Pharmacol; 2015; 10(4):279-98. PubMed ID: 26548905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
    Efferth T
    Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic role and therapeutic target of leptin signaling in colorectal cancer.
    Zhou W; Tian Y; Gong H; Guo S; Luo C
    Expert Opin Ther Targets; 2014 Aug; 18(8):961-71. PubMed ID: 24946986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy.
    Dias MH; Papagianni C; Bernards R
    Cancer Cell; 2024 Jun; 42(6):919-922. PubMed ID: 38788721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.
    Liu X; Ji Q; Fan Z; Li Q
    Future Oncol; 2015; 11(21):2911-22. PubMed ID: 26414153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and colorectal cancer: implications for therapy.
    Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
    Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).
    Ji Y; Lv J; Sun D; Huang Y
    Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34713301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway.
    Huang GL; Song W; Zhou P; Fu QR; Lin CL; Chen QX; Shen DY
    Cell Cycle; 2017 Apr; 16(7):685-692. PubMed ID: 28272990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks.
    Li J; Guo C; Lu X; Tan W
    Eur J Pharmacol; 2019 Sep; 858():172483. PubMed ID: 31233753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting key transcriptional factor STAT3 in colorectal cancer.
    Chalikonda G; Lee H; Sheik A; Huh YS
    Mol Cell Biochem; 2021 Sep; 476(9):3219-3228. PubMed ID: 33866491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback analysis identifies a combination target for overcoming adaptive resistance to targeted cancer therapy.
    Park SM; Hwang CY; Choi J; Joung CY; Cho KH
    Oncogene; 2020 May; 39(19):3803-3820. PubMed ID: 32157217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedyotis diffusa Willd inhibits colorectal cancer growth in vivo via inhibition of STAT3 signaling pathway.
    Cai Q; Lin J; Wei L; Zhang L; Wang L; Zhan Y; Zeng J; Xu W; Shen A; Hong Z; Peng J
    Int J Mol Sci; 2012; 13(5):6117-6128. PubMed ID: 22754353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment.
    Maurya NS; Mani A
    Curr Top Med Chem; 2023; 23(30):2821-2843. PubMed ID: 37317918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel targeting approaches and signaling pathways of colorectal cancer: An insight.
    Tiwari A; Saraf S; Verma A; Panda PK; Jain SK
    World J Gastroenterol; 2018 Oct; 24(39):4428-4435. PubMed ID: 30357011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways in colorectal cancer implications for the target therapies.
    Song Y; Chen M; Wei Y; Ma X; Shi H
    Mol Biomed; 2024 Jun; 5(1):21. PubMed ID: 38844562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.